Inappropriate Prescription of Direct Oral Anticoagulant Starter Packs

被引:1
|
作者
Feng, Yilin [1 ]
Pai, Chih-Wen [2 ]
Seiler, Kristian [3 ]
Barnes, Geoffrey D. [2 ,3 ]
机构
[1] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[2] Univ Michigan Hlth Syst, Frankel Cardiovasc Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA
来源
AMERICAN JOURNAL OF MEDICINE | 2021年 / 134卷 / 03期
基金
美国医疗保健研究与质量局;
关键词
Anticoagulation; Atrial fibrillation; Prescription; Starter pack; Thrombosis; RIVAROXABAN; WARFARIN; APIXABAN;
D O I
10.1016/j.amjmed.2020.06.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The 30-day direct oral anticoagulant starter pack has simplified the treatment of acute venous thromboembolisms, but it is not appropriate for use in patients with other indications for anticoagulation. METHODS: A retrospective analysis of national outpatient pharmacy claims data between January 1, 2015 and December 31, 2018, was performed. Adult patients (ages > 18 years) with continuous insurance enrollment at least 12 months prior to and 1 month following a direct oral anticoagulant starter pack prescription during the study period were included. The primary study outcome was the rate of inappropriate prescription of direct oral anticoagulant starter packs, defined as a prescription without a venous thromboembolism diagnosis within the prior 45 days or a prescription with a prior starter pack fill within the past 45 days. RESULTS: A total of 3711 direct oral anticoagulant starter pack prescription fills were identified, representing 3634 unique patients. The mean patient age was 62.8 years (standard deviation [SD] 15.1) and 1871 (50.4%) were females. There were 770 (20.7%) direct oral anticoagulant starter pack fills identified as potentially inappropriate. Patients prescribed inappropriate fills were likely to be older than patients with appropriate fills (64.7 years vs 62.4 years, P < 0.001). There was no significant difference in the race or geographic location between patients with inappropriate and appropriate prescriptions. CONCLUSIONS: A significant proportion of patients using direct oral anticoagulant starter packs did not have a diagnosis of acute venous thromboembolism, raising concerns about inappropriate prescribing and potential bleeding complications. Future studies are needed to identify factors associated with inappropriate direct oral anticoagulant starter pack prescription and evaluate efforts to reduce this practice. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:370 / +
页数:5
相关论文
共 50 条
  • [31] Starter packs: a good start to therapy?
    Patounas, Marea P.
    McGuire, M.
    [J]. AUSTRALIAN PRESCRIBER, 2007, 30 (01) : 14 - 16
  • [32] Prescription of Direct Oral Anticoagulant Affects Activated Clotting Time During Percutaneous Coronary Intervention and Clinical Outcomes
    Ebihara, Suguru
    Jujo, Kentaro
    Kamishima, Kazuho
    Shimazaki, Kensuke
    Moriyama, Tetsu
    Shiozaki, Natsuko
    Inagaki, Keiko
    Iwanami, Yuji
    Ishida, Issei
    Suzuki, Kazuhito
    Saito, Katsumi
    Hagiwara, Nobuhisa
    [J]. CIRCULATION, 2018, 138
  • [33] Development and Assessment of RecosDoc-MTeV to Improve the Quality of Direct Oral Anticoagulant Prescription for Venous Thromboembolic Disease
    Seroussi, Brigitte
    Ouarrirh, Houda
    Elalamy, Ismael
    Gerotziafas, Grigorios
    Debrix, Isabelle
    Bouaud, Jacques
    [J]. MEDINFO 2019: HEALTH AND WELLBEING E-NETWORKS FOR ALL, 2019, 264 : 793 - 797
  • [34] Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
    Bellamy, L.
    Rosencher, N.
    Eriksson, Bi
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 173 - 177
  • [35] Direct oral anticoagulant agents: Are they so safe?
    Manfredi, Maddalena
    [J]. ORAL DISEASES, 2019, 25 (05) : 1243 - 1244
  • [36] LABORATORY TESTING FOR DIRECT ORAL ANTICOAGULANT MONITORING
    Tripodi, Armando
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 183 - 183
  • [37] Progress in the monitoring of direct oral anticoagulant therapy
    Patel, Jignesh P.
    Byrne, Rosalind A.
    Patel, Raj K.
    Arya, Roopen
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (06) : 912 - 924
  • [38] Direct oral anticoagulant: Looking beyond convenience
    Koh, Samuel Ji Quan
    Yap, Jonathan Jiunn Liang
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2024, 53 (02) : 65 - 66
  • [39] The real prize of direct oral anticoagulant blockbuster
    Seiffge, David J.
    Meinel, Thomas Raphael
    [J]. HEART, 2021, 107 (01) : 8 - 9
  • [40] Pharmacists' role in the direct oral anticoagulant dilemma
    Singh, Suzanne
    [J]. CANADIAN FAMILY PHYSICIAN, 2020, 66 (02) : 93 - 93